The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan shuttlers knocked out of Thomas Cup by Indonesia
05/05/2024 04:30 PM - Society
Taiwan headline news
05/05/2024 12:17 PM - Culture
Taipei's Fubon museum featuring renowned collections and artworks opens
05/04/2024 10:13 PM - Culture
European Day event in Taipei celebrates 'unity in diversity'
05/04/2024 08:30 PM - Business
MediaTek chair touches on semiconductor innovation in award ceremony
05/04/2024 08:04 PM